Finance

Lists
Q2 2027 earnings • released • EPS miss -6.18% • Revenue beat +2.38%
See results
RAINBOW:NSE
Rainbow Children's Medicare Ltd
₹1,270.00
+1.89%
(+23.60) 1D
Nov 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RAINBOW...
Open
₹1,255.00
High
₹1,286.90
Low
₹1,235.00
Mkt. cap
129.05B
Avg. vol.
163.49K
Volume
128.75K
Dividend
0.28%
Quarterly dividend
₹0.87
Ex-dividend date
Jul 21, 2026
P/E ratio
44.11
52-wk high
₹1,610.00
52-wk low
₹1,084.00
EPS
₹28.79
No. of employees
5K
Open
₹1,255.00
High
₹1,286.90
Low
₹1,235.00
Mkt. cap
129.05B
Avg. vol.
163.49K
Volume
128.75K
Dividend
0.28%
Quarterly dividend
₹0.87
Ex-dividend date
Jul 21, 2026
P/E ratio
44.11
52-wk high
₹1,610.00
52-wk low
₹1,084.00
EPS
₹28.79
No. of employees
5K
News stories
From web sources and news partners
Profile
Rainbow Children's Medicare, commonly known as Rainbow Hospitals, is an Indian chain of paediatric hospitals headquartered in Hyderabad. Founded by Dr. Ramesh Kancharla in 1999, the hospital's main focus is paediatric and maternal healthcare services. The flagship facility of Rainbow Children's Hospitals is located at Banjara Hills, Hyderabad. The Rainbow Hospital Group currently operates out of 19 hospitals and 3 outpatient clinics – eight in Hyderabad, four in Bangalore, two each in Delhi, Chennai, Vijayawada, and Visakhapatnam. Wikipedia
About Rainbow Children's Medicare Ltd
CEO-
Employees4.72K
Founded1999
Headquarters-
SectorHealth care provider
Industry-
Websiterainbowhospitals.in
Last report
Nov 1, 2026
Fiscal period
Q2 2027
₹8.10 / ₹8.63
-6.18%miss
Revenue / Est. (INR)
5.48B / 5.35B
+2.38%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.45B
4.45B
4.60B
4.70B
Cost of goods sold
1.21B
1.20B
1.54B
1.31B
Cost of revenue
1.21B
1.20B
1.54B
1.31B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.06B
1.08B
1.44B
1.24B
Operating expense
2.11B
2.18B
2.02B
2.46B
Total operating expenses
3.32B
3.38B
3.56B
3.78B
Operating income
1.13B
1.07B
1.04B
924.48M
Other non operating income
81.95M
105.13M
-387.24M
127.10M
EBT including unusual items
1.02B
976.94M
867.91M
839.53M
EBT excluding unusual items
1.02B
976.94M
809.15M
839.53M
Income tax expense
267.46M
237.97M
85.73M
214.13M
Effective tax rate
26.13%
24.36%
9.88%
25.51%
Other operating expenses
686.21M
700.16M
165.57M
801.29M
Net income
752.50M
725.31M
770.43M
605.72M
Net profit margin
16.92%
16.28%
16.75%
12.89%
Earnings per share
7.41
7.14
7.73
5.97
Interest and investment income
-
-
363.09M
-
Interest expense
-188.49M
-201.95M
-204.95M
-212.05M
Net interest expenses
-188.49M
-201.95M
158.14M
-212.05M
Depreciation and amortization charges
358.41M
396.00M
409.42M
421.97M
EBITDA
1.48B
1.29B
1.27B
1.30B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps